Hepatitis B e antigen
Original Article Association of hepatitis B virus basal core promoter T1762/A1764 and precore A1896 mutations with serum hepatitis B virus DNA load, hepatitis B e antigen status, serum α-fetoprotein and hepatitis B virus-related liver disease progression
13
Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti HBcore and IgM anti HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria
5
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens Implications for hepatitis B e antigen seroconversion
11
Original Article Clinical prognosis of chronic hepatitis B patients with concurrent HBeAg/Anti-HBe detection and possible mechanism
8
Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
9
Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016–2017
11
Prevalence of Hepatitis B and Its Associated Factors Among Pregnant Women in Mogadishu, Somalia
24
Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients
9
Detection of pre C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers
10
A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
7
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
15
Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.
9
Safety and efficacy of entecavir for the treatment of chronic hepatitis B
10
Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
8
Prevention of mother to child transmission of hepatitis B virus: a phase III, placebo controlled, double blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e antigen
6
Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand Myanmar border: a cost effectiveness analysis
10
Safety of biologic and nonbiologic disease modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study
9
Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus.
11
Osteopontin promotes dendritic cell maturation and function in response to HBV antigens
14
Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma
8